Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Vanadium Compounds”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 685 records · Page 38Linked to original sources
PubMed2005

Structural, optical, physical and electrical properties of V2O5.SrO.B2O3 glasses.

The present work aims to study the structure and variation of optical band gap, density and dc electrical conductivity in vanadium strontium borate glasses. The glass systems xV2O5.(40-x)SrO.60B2O3 and xV2O5.(60-x)B2O3.40SrO with x varying from 0 to 20 mol% were prepared by normal melt quench technique. Structural studies were made by recording IR transmission spectra. The fundamental absorption edge for all the glasses was analyzed in terms of the theory proposed by Davis and Mott. The position of absorption edge and hence the value of the optical band gap was found to depend on the semiconducting glass composition. The absorption in these glasses is believed to be associated with indirect transitions. The origin of Urbach energy is associated with the phonon-assisted indirect transitions. The change in both density and molar volume was discussed in terms of the structural modifications that take place in the glass matrix on addition of V2O5. dc conductivity of the glass systems is also reported. The change of conductivity and activation energy with composition indicates that the conduction process varies from ionic to polaronic one.

Boron Compounds↗
PubMed1975

Comparative study of abiogenesis of cysteine and other amino acids catalyzed by various metal ions.

The present work pertains to the study of the influence of nickel, cobalt, thorium, vanadium, molybdate, ferrous ions on the formation of cysteine which is synthesized abiogenically together with other amino acids in sterilized aqueous mixtures of ammonium thiocyanate, formaldehyde, potassium dihydrogen phosphate, calcium acetate, and biological minerals after irradiating by artificial light. The effect of these catalysts on cysteine formation was of the order: Fe++ greater than Mo++ greater than Th++++ greater than V++ greater than Co++ greater than Ni.

Acetates↗
PubMed2005

Divalent metal transporter-1 decreases metal-related injury in the lung.

Exposure to airborne particulates makes the detoxification of metals a continuous challenge for the lungs. Based on the fate of iron in airway epithelial cells, we postulated that divalent metal transporter-1 (DMT1) participates in detoxification of metal associated with air pollution particles. Homozygous Belgrade rats, which are functionally deficient in DMT1, exhibited diminished metal transport from the lower respiratory tract and greater lung injury than control littermates when exposed to oil fly ash. Preexposure of normal rats to iron in vivo increased expression of the isoform of DMT1 protein that lacked an iron-response element (-IRE), accelerated metal transport out of the lung, and decreased injury after particle exposure. In contrast, normal rats preexposed to vanadium showed less expression of the -IRE isoform of DMT1, decreased metal transport, and greater pulmonary injury after particle instillation. Respiratory epithelial cells in culture gave similar results. Also, DMT1 mRNA and protein expression for the -IRE isoform increased or decreased in these cells when exposed to iron or vanadium, respectively. These results thus demonstrate for the first time a primary role for DMT1 in lung metal transport and detoxification.

Animals↗
PubMed1995

Binding of vanadium (IV) to the phosphatase calcineurin.

X-band electron spin resonance spectroscopy was used to study the binding of vanadium (IV), or vanadyl, to the brain serine/threonine phosphatase-2B, calcineurin. Spectra were determined on frozen solutions of vanadyl and calcineurin at pH 7.4 in the presence of 20% (v/v) glycerol. The binding of vanadyl to the enzyme was established, and the data suggested the presence of two classes of sites, the higher affinity class of which contained two binding sites for vanadyl. The calcium-binding B subunit of the heterodimeric protein was also shown to bind vanadyl. The holoprotein appeared to be stabilized by vanadyl, and vanadyl enhanced enzymatic activity when assayed with or without calmodulin in the absence of calcium.

Animals↗
PubMed2002

Preparation and characterization of vanadyl complexes with bidentate maltol-type ligands; in vivo comparisons of anti-diabetic therapeutic potential.

A series of 2-alkyl-3-hydroxy-4-pyrone oxovanadium(IV) compounds has been synthesized, characterized, and tested for bioactivity as potential insulin-enhancing agents. The vanadyl complexes, bis(maltolato)oxovanadium(IV), BMOV, bis(ethylmaltolato)oxovanadium(IV), BEOV, and bis(isopropylmaltolato)oxovanadium(IV), BIOV, were compared against vanadyl sulfate for glucose-lowering ability, when administered i.p. to STZ-diabetic rats, at a one-time dose of 0.1 mmol kg(-1)body weight. Blood levels of vanadium were determined at regular intervals, to 72 h, following i.p. injection. All complexes tested exceeded vanadyl sulfate in glucose-lowering ability; this effect was not correlated, however, with blood vanadium levels. Analysis of the pharmacokinetics of the disappearance of [ethyl-1-(14)C]BEOV after an oral gavage dose (50 mg kg(-1), 0.144 mmol kg(-1), in a 10 mL kg(-1) volume of 1% CMC solution) indicated clearly that metal ion-ligand dissociation took place relatively soon after oral ingestion of the complex. Half-lives of fast phase uptake and slow phase disappearance for (14)C and V were calculated from a two-compartment model for whole blood, plasma, liver, kidney, bone, small intestine, and lung, ranging from 17 min ( t(1/2)alpha for (14)C, liver) to 30 days ( t(1/2)beta for V, bone). Curves of disappearance of plasma and whole blood (14)C and V diverged dramatically within the first hour after administration of the vanadium complex.

Administration, Oral↗
PubMed1974

Electron transport to clostridial rubredoxin: kinetics of the reduction by hexaammineruthenium(II), vanadous and chromous ions.

The rate constants (25 degrees , M(-1) sec(-1)), activation enthalpies (kcal/mol), and activation entropies (e.u.) for the second-order reduction of oxidized clostridial rubredoxin by Ru(NH(3))(6) (2+), V(H(2)O)(6) (2+), and Cr(H(2)O)(6) (2+) at I = 0.10 have been determined or estimated to be 9.5 x 10(4), approximately 1.4, approximately -31 (pH 6.3-7.0); 1.6 x 10(4), 0.1, -40 (pH 3.5-4.5); and 1.2 x 10(3), approximately 0, approximately -44 (pH 3.5-4.0), respectively. Ionic strength dependencies for the vanadium reaction are suggestive of a direct interaction of the reductants with the Fe(SR)(4) (-1) site of oxidized rubredoxin. The results are consistent with outer-sphere mechanisms for all three reductants and an especially high inherent outer-sphere reactivity of rubredoxin. This high reactivity level is attributed to the low activation enthalpy demands of the iron-sulfur site of rubredoxin. Thus, the possibility is raised that the rate of reaction of rubredoxin with its physiological counterparts may be determined largely by the activation entropy demands imposed by the physiological reactant. Evidence is presented in support of an absolute entropy decrease of about 7.5 e.u. on going from oxidized to reduced rubredoxin, which is presumably attributable to the charge increase from Fe(SR)(4) (1-) to Fe(SR)(4) (2-) at the redox site.

Chromium↗
PubMed2005

Kinetic and mechanistic studies of vanadium-based, extended catalytic lifetime catechol dioxygenases.

Recently we showed that V-containing polyoxometalates such as (n-Bu4N)7SiW9V3O40 or (n-Bu4N)9P2W15V3O62, as well as eight other V-containing precatalysts tested, evolve to high-activity, long catalytic lifetime (> or = 30,000-100,000 total turnovers) 3,5-di-tert-butylcatechol (DTBC) dioxygenases in which Pierpont's complex [VO(DBSQ)(DTBC)]2 is apparently a common catalyst resting state [Yin, C.-X.; Finke, R. G. J. Am. Chem. Soc. 2005, 107, 9003-9013]. In a separate paper, autoxidation of DTBC to the corresponding benzoquinone and H2O2 was shown to be a key to the catalyst evolution process: the H2O2, DTBC, and O2 plus virtually any V-based precatalyst tested form [VO(DBSQ)(DTBC)]2 under the catalytic conditions, that catalyst formation process being autocatalytic in H2O2. The resulting novel concept is that of an autoxidation-product-initiated dioxygenase [Yin, C.-X.; Sasaki, Y.; Finke, R. G. Inorg Chem. 2005, in press]. Herein the following questions about this record catalytic lifetime 3,5-di-tert-butylcatechol dioxygenase catalyst are explored: (i) What is the rate law for 3,5-di-tert-butylcatechol dioxygenation when one begins with Pierpont's [VO(DBSQ)(DTBC)]2? (ii) Does it support the hypothesis that this complex is a catalyst resting state or, perhaps, even the true catalyst? (iii) Can a mechanism be written from that information and from the knowledge in the dioxygenase literature? The results answer each of these questions and provide considerable mechanistic insight into the most catalytically active and long-lived DTBC dioxygenase catalyst presently known.

Catalysis↗
PubMed1992

Alternative staining methods for Lowicryl sections.

A number of stains and stain combinations have been identified that, when used with the hydrophilic resin Lowicryl K11M, produce marked improvements over aqueous uranyl and lead salts (UA-Pb) in terms of low granularity, specificity, and range of components contrasted. Three test specimens, tobacco mosaic virus (TMV), starfish sperm, and cultured mouse fibroblasts, were used to evaluate stain characteristics. UA-Pb showed a preference for nuclei acids, which were stained specifically by osmium ammine-B at pH 1.5. A number of stain combinations in which UA was followed or preceded by salts containing barium, manganese, tungsten, molybdenum, and vanadium provided excellent staining of protein-containing components, each stain combination being unique in terms of the degree to which specific components were discriminated. These stains were particularly effective for visualizing internal components of the nucleus where a number of fibrillar and particulate structures not seen with UA-Pb were well contrasted.

Acrylic Resins↗
PubMed2005

Coordination chemistry and insulin-enhancing behavior of vanadium complexes with maltol C6H6O3 structural isomers.

Syntheses of vanadium complexes using the naturally occurring ligands isomaltol (Hima) and allomaltol (Hama), as well as a newly synthesized, potentially tetradentate diaminodipyrone [H(2)(en(ama)(2)], are reported. Complete characterization of the resulting compounds [trans-VO(ima)(2)(H(2)O), VO(ama)(2), V(ima)(3), V(ama)(3) and VO(en(ama)(2))], including X-ray crystallography analyses for trans-VO(ima)(2)(H(2)O) and V(ima)(3), are presented herein. Potentiometric titrations (25 degrees C, I = 0.16 M NaCl) were used to measure stability constants in the V(IV)-Hima system; these data were compared to previous data collected on the V(IV)-L (L = Hma, Hama) systems. The in vivo efficacy of these compounds to lower the blood glucose levels of STZ-diabetic rats was tested; all but VO(en(ama)(2)) produced significant decreases in plasma glucose levels. The results were compared to those of the benchmark compound BMOV [VO(ma)(2), bis(maltolato)oxovanadium(IV)], a known insulin-enhancing agent.

Animals↗
PubMed1997

Determination of trace amounts of vanadyl porphyrin in marine mussel tissues by high-performance liquid chromatography with both ultraviolet/visible and inductively coupled plasma atomic emission spectrometric detection.

An HPLC method with UV/VIS and ICP-AES detection is described for the determination of vanadyl porphyrins extracted from biological samples. A detection limit of 50 ng of vanadium was obtained. The method was used to determine these compounds following their extraction from tissues of mussels treated in laboratory experiments and collected during a 'Mussel Watch Programme'. This allowed some conclusions about vanadium speciation in marine organisms to be made. In the tissues of mussels, collected at several sites of the monitored area, which showed high vanadium concentrations, it was possible to establish the presence of this metal in the form of organometallic compounds.

Animals↗
PubMed1995

A note on individual differences in the urinary excretion of optical enantiomers of styrene metabolites and of styrene-derived mercapturic acids in humans.

Urine samples from 20 male workers in the polyester industry exposed by inhalation to styrene concentrations ranging from 29 to 41 ppm were investigated. Excretion products of styrene metabolism, mandelic acid and mercapturic acids, were purified from the urine over an extraction column packed with Porapak Q, with subsequent ether elution. The optical enantiomers R- and S-mandelic acid were then determined by thin layer chromatography (TLC) using chiral plate material and selective staining with vanadium pentoxide. Quantitative analysis of these compounds was performed using commercial reference substances. Styrene-specific mercapturic acids were analyzed by a modified TLC method, using synthesized reference substances. The concentration of racemic mandelic acid in the individual urine samples ranged from 80 to 1610 mg/l, and the ratio of the R- and S-enantiomers ranged from 0.7 to 2.2. These individual variations are not explained by differences in individual styrene exposure levels, or by differences in the concentration of the urine samples (in relation to creatinine excretion). Styrene-specific mercapturic acids were detected in the urine of only 1 of the 20 workers, at a concentration much lower than expected from previous investigations by others in humans and laboratory animals, in which less specific analytical methods had been used. The results point to marked interindividual differences in metabolism of styrene, probably related to enzyme polymorphisms.

Acetylcysteine↗
PubMed2004

Theoretical studies of the spin Hamiltonian parameters and the local structures for M2+ (M=Co, Mn, V and Ni) ions in CsMgCl3.

The spin Hamiltonian parameters (zero-field splitting D, g factors g parallel, g perpendicular and hyperfine structure constants A parallel, A perpendicular) for M2+ (M=Co, Mn, V and Ni) ions in CsMgCl3 are studied by using the perturbation formulas of the spin Hamiltonian parameters for 3dn (n=7, 5, 3, 8) ions in trigonal symmetry based on the cluster approach. In these formulas, the contributions to the spin Hamiltonian parameters from the admixture of d orbitals of the central ions with the p orbitals of the ligands and from the trigonal distortion are included and the parameters related to these effects can be obtained from the optical spectra and the local structures of the studied systems. Based on the studies, it is found that the local trigonal distortion angle beta in the M2+ impurity center is unlike that betaH (approximately 51.71 degrees) in the host CsMgCl3. The spin Hamiltonian parameters for these divalent ions in CsMgCl3 are also satisfactorily explained by using the local angle beta. The validity of the results is discussed.

Cesium↗
PubMed1992

1H and 51V NMR studies of the interaction of vanadate and 2-vanadio-3-phosphoglycerate with phosphoglycerate mutase.

The formation of complexes of vanadate with 2-phosphoglycerate and 3-phosphoglycerate have been studied using 51V nuclear magnetic resonance spectroscopy. Signals attributed to two 2,3-diphosphoglycerate analogues, 2-vanadio-3-phosphoglycerate and 2-phospho-3-vanadioglycerate, were detected but were not fully resolved from signals of inorganic vanadate and the anhydride formed between vanadate and the phosphate ester moieties of the individual phosphoglycerates. Equilibrium constants for formation of the two 2,3-bisphosphate analogues were estimated as 2.5 M-1 for 2-vanadio-3-phosphoglycerate and 0.2 M-1 for 2-phospho-3-vanadioglycerate. The results of the binding study are fully consistent with non-cooperativity in the binding of vanadiophosphoglycerate to the two active sites of phosphoglycerate mutase (PGM). 2-Vanadio-3-phosphoglycerate was found to bind to the dephospho form of phosphoglycerate mutase with a dissociation constant of about 1 x 10(-11) M at pH 7 and 7 x 10(-11) M at pH 8. Three signals attributed to histidine residues were observed in the 1H NMR spectrum of phosphoglycerate mutase. Two of these signals and also an additional signal, tentatively attributed to a tryptophan, underwent a chemical shift change when the vanadiophosphoglycerate complex was bound to the enzyme. The results obtained here are in accord with these vanadate-phosphoglycerate complexes being much more potent inhibitors of phosphoglycerate mutase than either monomeric or dimeric vanadate. The dissociation constant of 10(-11) M for 2-vanadio-3-phosphoglycerate is about 4 orders of magnitude smaller than the Km for PGM, a result in accordance with the vanadiophosphoglycerates being transition state analogues for the phosphorylation of PGM by 2,3-diphosphoglycerate.(ABSTRACT TRUNCATED AT 250 WORDS)

Binding Sites↗
PubMed2002

Infrared spectra of gas-phase V(+)-(benzene) and V(+)-(benzene)(2) complexes.

The organometallic ions V+-(benzene) and V+-(benzene)2 are produced by laser vaporization in a pulsed nozzle source. They are trapped and mass selected in an ion-trap/time-of-flight mass spectrometer, and their infrared spectra are measured with resonance-enhanced multiphoton photodissociation (IR-REMPD) spectroscopy with a tunable free-electron laser. Vibrational bands in the 600-1800 cm-1 region are characteristic of the benzene molecular moiety perturbed by the metal cation bonding. Experimental data are compared to the IR spectra derived from density functional calculations. Vibrational patterns in V+-(C6H6) indicate that the metal is bound in an eta6 pi-bonding configuration, while V+-(C6H6)2 is a sandwich. Trapped-ion IR-REMPD is a general method to access the vibrational spectroscopy of organometallic ions and their clusters.

Benzene Derivatives↗
PubMedDate not supplied

Implantable power-sources: a review.

It has now been 25 years since the first pacemakers were implanted. It is indeed fascinating to see the breadth and the vision of the early investigators on both sides of the ocean, most of them friends of the author, in the almost desperate search for a power source that would enable the pacemaker to last as long as the expected lifetime of the average patient. Every conceivable method of power generation, power storage, and energy conservation was studied. The result was an orderly transition from zinc-mercury batteries, to lithium-iodine batteries, to the newest lithium oxyhalide systems of the coming decade, all of which coincided with tentative sidesteps into rechargeable batteries and nuclear batteries. This paper traces this 25 years of progress and salutes the many investigators who have brought the implantable pacemaker and its power source to their present state of acceptance by the medical profession.

Bioelectric Energy Sources↗